Resistance patterns of Campylobacter spp. strains isolated from poultry carcasses in a big Swiss poultry slaughterhouse

International Journal of Food Microbiology

Volumn 89, Issue 2-3, 2003, Pages 233-240

  Frediani Wolf, V ^a   Stephan, R ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Broth dilution method; Campylobacter strains; Disc diffusion; E test; Poultry carcasses; Resistance patterns

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; ERYTHROMYCIN; STREPTOMYCIN; TETRACYCLINE;

ACCURACY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CAMPYLOBACTER JEJUNI; CARCASS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIFFUSION; DILUTION; GENETIC SUSCEPTIBILITY; HERD; IN VITRO STUDY; NONHUMAN; POULTRY; RELIABILITY; SLAUGHTERHOUSE; SWITZERLAND; TECHNIQUE; VETERINARY MEDICINE;

CAMPYLOBACTER; CAMPYLOBACTER JEJUNI;

EID: 0242457297     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1605(03)00152-1     Document Type: Article

References (33)

1. Aarestrup F.M., Nielsen E.M., Madsen M., Engberg J. Antimicrobial susceptibility patterns of thermophilic Campylobacter spp. from humans, pigs, cattle, and broilers in Denmark. Antimicrob. Agents Chemother. 41:1997;2244-2250.
2. Aarestrup F.M., Bager F., Jensen N.E., Madsen M., Meyling A., Wegener H.C. Resistance to antimicrobial agents used for animal therapy in pathogenic-, zoonotic- and indicator bacteria isolated from different food animals in Denmark: a baseline study for the Danish Integrated Antimicrobial Resistance Monitoring Programme (DANMAP). APMIS, Acta Pathol. Microbiol. Immunol. Scand. 106:1998;745-770.
3. Allos B.M. Association between Campylobacter infection and Guillain-Barre syndrome. J. Infect. Dis. 176:1997;125-128.
4. Allos B.M., Lippy F.T., Carlsen A., Washburn R.G., Blaser M.J. Campylobacter jejuni strains from patients with Guillain-Barre syndrome. Emerg. Infect. Dis. 4:1998;263-268.
5. Altekruse S.F., Stern N.J., Fields P.I., Swerdlow D.L. Campylobacter jejuni - an emerging foodborne pathogen. Emerg. Infect. Dis. 5:1999;28-35.
6. Anonymous, 2001. Meldungen Infektionskrankheiten, Bulletin 20/01. Bundesamt für Gesundheit, Bern.
7. Bager F. DANMAP: monitoring antimicrobial resistance in Denmark. Int. J. Antimicrob. Agents. 14:2000;271-274.
8. Bager F., Emborg H.-D., Hovgaard K., Boel J., Jørgensen T.R., Sørensen T.L. DANMAP 98 - Consumption of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Bacteria from Food Animals, Food and Humans in Denmark. 1998;The Danish Integrated Antimicrobial Resistance Monitoring and Research Programme, Copenhagen, Denmark.
9. Baker C.N. The E-Test and Campylobacter jejuni. Diagn. Microbiol. Infect. Dis. 15:1992;469-472.
10. Butzler J.P., Oosterom J. Campylobacter: pathogenicity and significance in foods. Int. J. Food Microbiol. 12:1991;1-8.
11. Caprioli A., Busani L., Martel J.L., Helmuth R. Monitoring of antibiotic resistance in bacteria of animal origin: epidemiological and microbiological methodologies. Int. J. Antimicrob. Agents. 14:2000;295-301.
12. Endtz H.P., Ruijs G.J., van Klingeren B., Jansen W.H., van der Reyden T., Mouton R.P. Quinolone resistance in Campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J. Antimicrob. Chemother. 27:1991;199-208.
13. Engberg J., Andersen S., Skov R., Aarestrup F.M., Gerner-Smidt P. Comparison of two agar dilution methods and three agar diffusion methods, including the E-test, for antibiotic susceptibility testing of thermophilic Campylobacter species. Clin. Microbiol. Infect. 5:1999;580-584.
14. Engberg J., Aarestrup F.M., Taylor D.E., Gerner-Smidt P., Nachamkin I. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg. Infect. Dis. 7:2001;24-34.
15. Frost J.A., Oza A.N., Thwaites R.T., Rowe B. Serotyping scheme for Campylobacter jejuni and Campylobacter coli based on direct agglutination of heat-stable antigens. J. Clin. Microbiol. 36:1998;335-339.
16. Gaudreau C., Gilbert H. Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter coli. J. Antimicrob. Chemother. 39:1997;707-712.
17. Gaunt P.N., Piddock L.J. Ciprofloxacin resistant Campylobacter spp. in humans: an epidemiological and laboratory study. J. Antimicrob. Chemother. 37:1996;747-757.
18. Gootz T.D., Martin B.A. Characterization of high-level quinolone resistance in Campylobacter jejuni. Antimicrob. Agents Chemother. 35:1991;840-845.
19. Huang M.B., Baker C.N., Banerjee S., Tenover F.C. Accuracy of the E test for determining antimicrobial susceptibilities of staphylococci, enterococci, Campylobacter jejuni, and gram-negative bacteria resistant to antimicrobial agents. J. Clin. Microbiol. 30:1992;3243-3248.
20. Jacobs-Reitsma W.F., Kan C.A., Bolder N.M. The introduction of quinolone resistance in Campylobacter bacteria in broilers by quinolone treatment. Lett. Appl. Microbiol. 19:1994;228-231.
21. Jacobs-Reitsma W.F., Koenraad P.M., Bolder N.M., Mulder R.W. In vitro susceptibility of Campylobacter and Salmonella isolates from broilers to quinolones, ampicillin, tetracycline, and erythromycin. Vet. Q. 16:1994;206-208.
22. Nachamkin I., Allos B.M., Ho T. Campylobacter species and Guillain-Barre syndrome. Clin. Microbiol. Rev. 11:1998;555-567.
23. National Committee for Clinical Laboratory Standards Performance Standards for Antimicrobial Disc Susceptibility Tests - 6th Edition: Approved Standard M2-A6. 1997;NCCLS, Villanova, PA.
24. National Committee for Clinical Laboratory Standards Performance Standards for Antimicrobial Disc Susceptibility Tests - 6th Edition: Approved Standard M7-A3. 1997;NCCLS, Villanova, PA.
25. McCarthy N., Andersson Y., Jormanainen V., Gustavsson O., Giesecke J. The risk of Guillain-Barre syndrome following infection with Campylobacter jejuni. Epidemiol. Infect. 122:1999;15-17.
26. Rautelin H., Renkonen O.V., Kosunen T.U. Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland. Antimicrob. Agents Chemother. 35:1991;2065-2069.
27. Reina J., Borrell N., Serra A. Emergence of resistance to erythromycin and fluoroquinolones in thermotolerant Campylobacter strains isolated from feces 1987-1991. Eur. J. Clin. Microbiol. Infect. Dis. 11:1992;1163-1166.
28. Smith K.E., Besser J.M., Hedberg C.W., Leano F.T., Bender J.B., Wicklund J.H., Johnson B.P., Moore K.A., Osterholm M.T. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team. N. Engl. J. Med. 340:1999;1525-1532.
29. Skirrow M.B. Campylobacter enteritis: a "new" disease. Br. Med. J. 2:1977;9-11.
30. Solomon E.B., Hoover D.G. Campylobacter jejuni: a bacterial paradox. J. Food Saf. 19:1999;121-136.
31. Van Looveren M., Daube G., De Zutter L., Dumont J.M., Lammens C., Wijdooghe M., Vandamme P., Jouret M., Cornelis M., Goossens H. Antimicrobial susceptibilities of Campylobacter strains isolated from food animals in Belgium. J. Antimicrob. Chemother. 48:2001;235-240.
32. Velazquez J.B., Jimenez A., Chomon B., Villa T.G. Incidence and transmission of antibiotic resistance in Campylobacter jejuni and Campylobacter coli. J. Antimicrob. Chemother. 35:1995;173-178.
33. Wray C., Gnanou J.C. Antibiotic resistance monitoring in bacteria of animal origin: analysis of national monitoring programmes. Int. J. Antimicrob. Agents. 14:2000;291-294.